Hemorrhoids Treatment Market Summary
The Global Hemorrhoids Treatment Market Size Was Estimated at USD 728.03 Million in 2024 and is Projected to Reach USD 1646.23 Million by 2035, Growing at a CAGR of 7.7% from 2025 to 2035. The market for hemorrhoids treatment is growing due to several factors, including the increasing incidence of hemorrhoidal disorders, sedentary lifestyles, poor diets, increased awareness of minimally invasive procedures, improvements in treatment technologies, and increased access to healthcare and over-the-counter drugs worldwide.
 
Key Regional and Segment-Wise Insights
	- In 2024, the North America hemorrhoids treatment market held the largest revenue share of 41.52% and dominated the global market.
- In 2024, the internal hemorrhoids segment held the highest revenue share of 46.75% and dominated the global market by disease.
- With the biggest revenue share of 48.37% in 2024, the corticosteroid segment led the worldwide hemorrhoids treatment market by drug class.
 
Global Market Forecast and Revenue Outlook
	- 2024 Market Size: USD 728.03 Million
- 2035 Projected Market Size: USD 1646.23 Million
- CAGR (2025-2035): 7.7%
- North America: Largest market in 2024
- Asia Pacific: Fastest growing market

The market for hemorrhoids treatment consists of various treatment options, medications, and surgical procedures which aim to manage and cure hemorrhoidal diseases that cause swollen veins in the anus and lower rectum. These lead to pain, bleeding, and discomfort. The worldwide market for hemorrhoids treatment continues to grow because more people develop haemorrhoids from their inactive way of living, their unhealthy diet choices, and the increasing number of overweight individuals. The market expansion receives support from both over-the-counter (OTC) creams and ointments, suppositories, and from increasing public awareness about early detection and treatment methods. The worldwide market for hemorrhoid management solutions experiences growth because emerging nations develop their healthcare systems, and patients require both non-surgical treatments and surgical procedures for serious hemorrhoid cases.
 
Technological advancements have brought major changes to the market for hemorrhoid treatment products. The medical field has developed new treatment methods through laser-based therapies, infrared coagulation systems, and rubber band ligation devices, which provide less invasive procedures that lead to quicker recovery times. The development of improved pharmacological formulations, which include analgesic and anti-inflammatory drugs, has resulted in better patient compliance. The government, together with healthcare organisations, funds screening programs, research initiatives, and awareness campaigns to support early intervention efforts. The expanding clinical adoption of advanced therapeutic technology drives market growth. This produces better patient results worldwide.
 
Disease Insights

The internal hemorrhoids segment led the hemorrhoids treatment market with the largest revenue share of 46.75% in 2024. Internal hemorrhoids appear more frequently than external ones because they develop slowly and result from poor diet choices, prolonged sitting, and constipation problems. The requirement for therapeutic solutions arises from the frequent necessity to treat internal hemorrhoids through medical procedures and treatments, including rubber band ligation, minimally invasive interventions, and pharmaceutical options. Early diagnosis, combined with patient awareness growth, drives up therapy adoption rates. The worldwide hemorrhoids treatment market shows internal hemorrhoids treatment as the leading segment because of new drug treatments and medical procedure advancements, and expanded healthcare service availability.
 
The mixed hemorrhoids segment of the hemorrhoids treatment market is anticipated to experience substantial growth throughout the forecast period. The number of patients with internal and external hemorrhoids has increased, which requires complete treatment plans for effective care. The complex nature of mixed hemorrhoids requires advanced minimally invasive procedures, including stapled hemorrhoidopexy and laser therapy. This drives up market demand alongside pharmaceutical treatment options. The segment grows because diagnostic methods have improved, and patients now understand the need for fast and efficient medical care. The global mixed hemorrhoids market expands because healthcare professionals focus on better patient results and reduced recurrence rates.
 
Drug Class Insights
The corticosteroid segment leads the hemorrhoids treatment market with the largest revenue share of 48.37% in 2024. Hemorrhoidal symptoms treatment mainly depends on corticosteroid-based creams, ointments, and suppositories, which help patients manage their pain and swelling. Inflammation. Healthcare providers and patients choose corticosteroids as the preferred treatment for both internal and external hemorrhoids because they provide fast relief from symptoms. The demand for topical hemorrhoid treatments continues to grow because chronic hemorrhoidal conditions are becoming more common, and patients seek effective topical solutions. The worldwide hemorrhoid treatment market receives its dominant position from this segment through improved safety profiles, enhanced corticosteroid formulations, and easy access to over-the-counter products.
 
The vasoconstrictors segment of the hemorrhoids treatment market is expected to grow at a significant rate during the forecast period. The market expansion occurs because doctors use vasoconstrictor treatments, which reduce blood flow through affected areas to decrease bleeding, swelling, and inflammation. The market expansion occurs due to increasing patient preference for minimally invasive treatments and fast symptom relief solutions. The market continues to grow because formulation technology advancements create better topical gels and suppositories. These deliver superior performance with fewer side effects. The segment experiences rapid worldwide expansion because of better access to over-the-counter vasoconstrictor products and increasing public knowledge about starting treatment early.
 
Regional Insights
The North American hemorrhoid treatment market led globally with the largest revenue share of 41.52% in 2024. The area leads the world in hemorrhoidal problems because people lead inactive lives while eating poorly and facing growing rates of obesity. The market position depends on a complex healthcare system together with available prescription, over-the-counter drugs, and early adoption of minimally invasive procedures such as laser therapy, infrared coagulation, and rubber band ligation. Market growth continues because patients understand early detection benefits and treatment choices, and insurance systems support these services. Medical expenses remain substantial. North America maintains its global leadership position because major pharmaceutical companies exist in the region, while scientists keep developing new hemorrhoid treatment methods.
 
Europe Hemorrhoids Treatment Market Trends
Europe held a significant revenue share in hemorrhoids treatment because hemorrhoidal problems have become more common, and people now understand the importance of early detection, and new treatment methods have become widely available. The well-established healthcare systems and extensive access to both pharmaceutical and procedural medicines in nations like Germany, the United Kingdom, and France allow them to make significant contributions. The area benefits from the availability of minimally invasive procedures that enhance patient outcomes and recovery times, such as laser-based therapies, infrared coagulation, and rubber band ligation. The market expansion receives support from government programs, which offer positive reimbursement policies. Active research and development activities for hemorrhoidal disease treatments also contribute. The worldwide market position of Europe is being reinforced by rising healthcare spending and patient awareness.
 
Asia-Pacific Hemorrhoids Treatment Market Trends
The Asia-Pacific hemorrhoids treatment market is expected to grow at the fastest CAGR during the forecast period because sedentary lifestyles, poor dietary choices, and increasing obesity rates lead to more cases of hemorrhoidal problems. The market growth stems from expanding hospital networks, fast healthcare infrastructure development, and increasing availability of advanced diagnostic and treatment equipment in China, India, and Japan. The healthcare system has achieved faster patient access and treatment through minimally invasive procedures and expanded availability of both prescription and over-the-counter medications. The fast economic growth of the Asia-Pacific region as a leading global market happens because governments actively support research and development for hemorrhoidal disease management. Public education about early detection.
 
Key Hemorrhoids Treatment Companies:
The following are the leading companies in the hemorrhoids treatment market. These companies collectively hold the largest market share and dictate industry trends.
	- Lupin
- Abbott
- Haleon Group of Companies
- Cipla
- Church & Dwight Co., Inc
- Bayer AG
- Sanofi
- Sebela Pharmaceuticals
- Amato Pharmaceutical Products, Ltd.
- Sun Pharmaceutical Industries, Inc
- Others
 
Recent Developments
	- In June 2025, Haleon plc paid roughly USD 225 million (RMB 1,623 million) to acquire the remaining 12% equity interest in Tianjin TSKF Pharmaceutical Co. Ltd (TSKF), its China-based OTC joint venture.
 
	- In March 2024, in Italy, Karo Healthcare purchased the rights to the over-the-counter hemorrhoid brand Proctosedyl from Bayer. An exclusive license for the Italian market and worldwide dossier ownership were part of the agreement.
 
Market Segment
This study forecasts revenue at global, regional, and country levels from 2020 to 2035. Decision Advisors has segmented the hemorrhoids treatment market based on the below-mentioned segments:  
 
Global Hemorrhoids Treatment Market, By Disease
	- Internal Hemorrhoids
- External Hemorrhoids
- Mixed Hemorrhoids
 
Global Hemorrhoids Treatment Market, By Drug Class
	- Corticosteroids
- Local Anesthetics
- Vasoconstrictors
- Others
 
Global Hemorrhoids Treatment Market, By Regional Analysis
	- North America 
	
	
- Europe 
	
		- Germany
- UK
- France
- Italy
- Spain
- Russia
- Rest of Europe
 
- Asia Pacific 
	
		- China
- Japan
- India
- South Korea
- Australia
- Rest of Asia Pacific
 
- South America 
	
		- Brazil
- Argentina
- Rest of South America
 
- Middle East & Africa 
	
		- UAE
- Saudi Arabia
- Qatar
- South Africa
- Rest of the Middle East & Africa